319 related articles for article (PubMed ID: 16555974)
1. Cancer biomarkers: knowing the present and predicting the future.
Chatterjee SK; Zetter BR
Future Oncol; 2005 Feb; 1(1):37-50. PubMed ID: 16555974
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers of prostate cancer.
Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
[TBL] [Abstract][Full Text] [Related]
3. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
4. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
Watson AP; Egland KA
S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
[TBL] [Abstract][Full Text] [Related]
5. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.
Bickers B; Aukim-Hastie C
Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
Sardana G; Jung K; Stephan C; Diamandis EP
J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
[TBL] [Abstract][Full Text] [Related]
7. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
8. Beyond prostate-specific antigen: alternate serum markers.
RamÃrez ML; Nelson EC; Evans CP
Prostate Cancer Prostatic Dis; 2008; 11(3):216-29. PubMed ID: 18227856
[TBL] [Abstract][Full Text] [Related]
9. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
10. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for prostate cancer detection.
Parekh DJ; Ankerst DP; Troyer D; Srivastava S; Thompson IM
J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845
[TBL] [Abstract][Full Text] [Related]
12. Biological markers in breast cancer prognosis and treatment.
Kesisis G; Kontovinis LF; Gennatas K; Kortsaris AH
J BUON; 2010; 15(3):447-54. PubMed ID: 20941809
[TBL] [Abstract][Full Text] [Related]
13. Oncoproteomics: current trends and future perspectives.
Cho WC; Cheng CH
Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
[TBL] [Abstract][Full Text] [Related]
14. The footprints of cancer development: Cancer biomarkers.
Ullah MF; Aatif M
Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for prostate cancer.
Makarov DV; Loeb S; Getzenberg RH; Partin AW
Annu Rev Med; 2009; 60():139-51. PubMed ID: 18947298
[TBL] [Abstract][Full Text] [Related]
16. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry.
Garbis SD; Tyritzis SI; Roumeliotis T; Zerefos P; Giannopoulou EG; Vlahou A; Kossida S; Diaz J; Vourekas S; Tamvakopoulos C; Pavlakis K; Sanoudou D; Constantinides CA
J Proteome Res; 2008 Aug; 7(8):3146-58. PubMed ID: 18553995
[TBL] [Abstract][Full Text] [Related]
17. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis].
Ohori M
Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen.
Fradet Y
Curr Opin Urol; 2009 May; 19(3):243-6. PubMed ID: 19325493
[TBL] [Abstract][Full Text] [Related]
19. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
Matharoo-Ball B; Ball G; Rees R
Vaccine; 2007 Sep; 25 Suppl 2():B110-21. PubMed ID: 17916461
[TBL] [Abstract][Full Text] [Related]
20. Blood biomarkers for prostate cancer detection and prognosis.
Shariat SF; Karam JA; Roehrborn CG
Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
